Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

Technology Information Technology Services
Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. It provides software-based services to assist health specialists in the detection of diabetic retinopathy and other eye-related pathologies. Its geographical areas include Canada, the United States of America, Mexico, and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.


TSXV:ADK - Post by User

Diagnos Inc
Bullboard Posts
User Avatar Image
(337)
•••
Comment by u2bobon Nov 06, 2017 11:25am
84 Views
Post# 26911774

RE:RE:SP

RE:RE:SP
scorpio40 wrote: When discussing MICRO-CAP companies, let me simply state that IMHO, Andr is one of the most, if not the most hardest working CEO's that I have ever met. While other CEO's spend shareholder's money on marketing their B.S to the naive and penny flippers, that in most cases end up as 'pump and dumps', Andr is laser focussed on generating revenues and signing deals. As the saying goes ***Build and they will come***

So to all longs, sit back, digest the importance of each and every one of the future press releases and enjoy the ride.



Scorp I agree Andre is a hard working CEO...As to the second part enjoying the ride not so much !

Lets hope that the 8 million shares sold will be the end of the selling pressure and we really can enjoy the ride !

Goood luck...
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities